The outcome and timing of death of 17,767 nosocomial bloodstream infections in acute care hospitals in Finland during 1999–2014

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2018-02-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10096-018-3211-0PMID 29455272
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms

  2017cited by this paper
• Early deaths in bloodstream infections: a population-based case series

  2016cited by this paper
• Etiology, clinical course and outcome of healthcare-associated bloodstream infections in patients with hematological malignancies: a retrospective study of 350 patients in a Finnish tertiary care hospital

  2015cited by this paper
• Characteristics of Hospital-Acquired and Community-Onset Blood Stream Infections, South-East Austria

  2014cited by this paper
• Population-based burden of bloodstream infections in Finland.

  2012cited by this paper
• The distinct category of healthcare associated bloodstream infections

  2012cited by this paper
• Temporal changes in the incidence and 30-day mortality associated with bacteremia in hospitalized patients from 1992 through 2006: a population-based cohort study.

  2011cited by this paper
• Clinical outcomes of health-care-associated infections and antimicrobial resistance in patients admitted to European intensive-care units: a cohort study.

  2011influential reference
• Long-term mortality associated with community-onset bloodstream infection

  2011cited by this paper
• Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs.

  2010cited by this paper
• Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007

  2010cited by this paper
• Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals.

  2010cited by this paper
• Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli

  2010cited by this paper
• Epidemiology of nosocomial bloodstream infections in Estonia.

  2009cited by this paper
• Bloodstream infections in adults: importance of healthcare-associated infections.

  2008cited by this paper
• Defining the population-based burden of nosocomial pneumococcal bacteremia.

  2007cited by this paper
• Risk factors for ineffective therapy in patients with bloodstream infection.

  2005cited by this paper
• Pseudomonas aeruginosa Bloodstream Infection: Importance of Appropriate Initial Antimicrobial Treatment

  2005cited by this paper
• Severe bloodstream infections: A population-based assessment*

  2004influential reference
• Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.

  2004cited by this paper
• Epidemiology and Outcome of Nosocomial and Community-Onset Bloodstream Infection

  2003cited by this paper
• Nosocomial bloodstream infections in Finnish hospitals during 1999-2000.

  2002cited by this paper
• Nosocomial bloodstream infections in United States hospitals: a three-year analysis.

  1999cited by this paper
• The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

  1998cited by this paper
• Patients with bacteremia dying before notification of positive blood cultures: a 3-year clinical study.

  1997cited by this paper
• CDC definitions for nosocomial infections.

  1989cited by this paper
• CDC definitions for nosocomial infections, 1988.

  1989cited by this paper
• CDC definitions for nosocomial infections, 1988.

  1988cited by this paper

• COVID-19 pandemic increased ESKAPEEc bloodstream infections and amplified carbapenem resistance in Chinese children: a multicenter surveillance study (2016–2023)

  2025cites this paper
• An Explanatory Model of Vascular Access Care Quality: Results of a Cross-Sectional Observational Study

  2024cites this paper
• Patterns, Cost, and Immunological Response of MDR vs. Non MDR-Bacteremia: A Prospective Cohort Study

  2023cites this paper
• ANTIMICROBIAL RESISTANCE AND MORTALITY

  2022cites this paper
• Hospital-acquired infections caused by enterococci: a systematic review and meta-analysis, WHO European Region, 1 January 2010 to 4 February 2020

  2021influential citation
• Risk factors for hospital-acquired bacteraemia – an explorative case–control study of hospital interventions

  2021cites this paper
• Epidemiology and Risk Factors Associated With Mortality in Consecutive Patients With Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria

  2020cites this paper
• Carbapenemase-producing Enterobacteriaceae in a Portuguese hospital - a five-year retrospective study.

  2020cites this paper
• The Significance of High-throughput Genome Sequencing for the Diagnosis of Neonatal and infant Septicemia

  2019cites this paper
• Healthcare-associated bloodstream infection trends under a provincial surveillance program

  2019cites this paper